PharmaCorp Rx P/TBV

Price to Tangible Book Value (P/TBV) of PharmaCorp Rx is 5.60 in 2026.

Price to Tangible Book Value (P/TBV) of PharmaCorp Rx changed from 33.82 to 5.60, representing a -83.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s PharmaCorp Rx with sector peers and the industry average to assess whether it is attractive.